Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Critical Reviews in Oncology/Hematology
|
September 5, 2024
The emerging role of Artificial Intelligence in proton therapy: A review
Lars Johannes Isaksson, Federico Mastroleo, Maria Giulia Vincini, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
JAMA Oncology
|
April 30, 2026
Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-Analysis
Marcin Miszczyk, Federico Mastroleo, Anna Kujawska, et al.
Clinical Lung Cancer
|
December 5, 2023
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
Paolo Borghetti, Giorgio Facheris, Patrizia Ciammella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2025
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)
Giulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
European Urology
|
July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
Cancer Treatment Reviews
|
May 9, 2021
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
Barbara A Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Critical Reviews in Oncology/Hematology
|
September 5, 2024
The emerging role of Artificial Intelligence in proton therapy: A review
Lars Johannes Isaksson, Federico Mastroleo, Maria Giulia Vincini, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Critical Reviews in Oncology/Hematology
|
January 20, 2019
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity
Stefano Arcangeli, Barbara Alicia Jereczek-Fossa, Filippo Alongi, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, et al.
The Lancet. Oncology
|
February 5, 2026
Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration
Chad Tang, Alex D Sherry, Hyunsoo Hwang, et al.
JAMA Oncology
|
April 30, 2026
Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy: A Systematic Review and Meta-Analysis
Marcin Miszczyk, Federico Mastroleo, Anna Kujawska, et al.
Clinical Lung Cancer
|
December 5, 2023
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort
Paolo Borghetti, Giorgio Facheris, Patrizia Ciammella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 15, 2025
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START)
Giulio Francolini, Vanessa Di Cataldo, Saverio Caini, et al.
European Urology
|
July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
Cancer Treatment Reviews
|
May 9, 2021
Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus
Barbara A Jereczek-Fossa, Giulia Marvaso, Mattia Zaffaroni, et al.
Page
of 17